Category: Clinical Breakthroughs
-
Clinical Trial Assesses Non-Hodgkin Lymphoma Drug
A recent clinical trial assessed the efficacy and safety of the drug ibrutinib in patients with Waldenstrom’s macroglobulineaemia, a type of non-Hodgkin lymphoma, who were not responding to other treatments.
-
Antiviral Drug Prevents Recurrence of Hepatitis C in Liver Transplant Patients
Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine clinical trial.
-
Testing a New Treatment for Crohn’s Disease
A drug called ustekinumab significantly improved symptoms for patients with moderate to severe Crohn’s disease, according to Northwestern Medicine clinical trials published in the New England Journal of Medicine.
-
Fellow Quantifies Healthy Years Gained by Avoiding Heart Failure Risk Factors
The absence of obesity, diabetes and hypertension in middle age was associated with significantly fewer years lived with heart failure, according to a Northwestern Medicine study.
-
Living After Cancer
Northwestern’s Cancer Survivorship Institute addresses the medical, psychological and social challenges patients face after their cancer is gone.
-
Investigating Coronary Artery Calcification in Low-Risk Women
Coronary artery calcium — a sign of atherosclerosis — was found in more than one-third of women previously considered to be low-risk for heart disease, according to a Northwestern Medicine study.
-
Unlocking the Secrets to ‘SuperAging’
Northwestern investigators want to know why some people are immune to age-related cognitive decline. Their answers could inform future therapies for neurodegenerative diseases like Alzheimer’s.
-
Hope For Fertility — in the Face of Cancer
Through pioneering research in oncofertility, reproductive endocrinologist Teresa Woodruff, PhD, offers young cancer survivors options to have children.
-
Medical Student Investigates Opioid Prescription Practices in Sickle Cell Disease
Standard guidelines are needed for prescribing opioids to children discharged after a sickle cell disease pain episode, according to a recent Northwestern Medicine study.
-
Scientists Develop Soft, Microfluidic ‘Lab on the Skin’ for Sweat Analysis
A Northwestern research team has developed a first-of-its-kind flexible microfluidic device that adheres to the skin and measures the wearer’s sweat.
